Cohance Lifesciences shares fell over 10% to a 52-week low after MD V Prasada Raju resigned. The pharma firm also faces USFDA "Official Action Indicated" status for its Hyderabad facilityCohance Lifesciences shares fell over 10% to a 52-week low after MD V Prasada Raju resigned. The pharma firm also faces USFDA "Official Action Indicated" status for its Hyderabad facility Latest News [ SOBAN NEWS: International and National ]
